Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/030089160609200313 | DOI Listing |
Clin Genitourin Cancer
December 2024
Clinica Luganese Moncucco, Lugano, Switzerland; Sant'Anna Clinic, Swiss Medical Group, Sorengo, Switzerland.
Objective: Sparse data exist on the impact of upper urinary tract (UUT) decompression on the risk of UUT recurrence in patients with bladder cancer (BCa). This study aims to evaluate whether Double J stenting (DJS) can increase the risk of UUT recurrence compared to percutaneous nephrostomy (PCN) placement.
Materials And Methods: We retrospectively analyzed data from 1550 patients with cTa-T3NanyM0 BCa who underwent radical cystectomy (RC) between at 12 tertiary care centers (1990-2020).
Surg Endosc
December 2024
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka, 812-8582, Japan.
Minerva Urol Nephrol
August 2024
Department of Urology, University Hospital Essen, Essen, Germany.
Background: It is controversial whether the use of a double-J stent (DJ) in patients with bladder cancer before radical cystectomy (RC) increases the risk of tumour seeding in the upper tract and thus the risk of metachronous upper tract urothelial carcinoma (UTUC). The aim of our study is to investigate the risk of upper tract recurrence after RC in patients previously managed with a DJ stent.
Methods: A total of 699 patients who had undergone RC between January 2003 and March 2022 with complete perioperative data and pathological outcome were included in our study.
J Cancer Res Ther
April 2024
Department of Radiation Oncology, SGRD Institute of Medical Sciences and Research, Amritsar, Punjab, India.
Background: This study aims to report the increasing incidence of second primary malignancies to better understand the association of multiple primary cancers and the duration of their occurrence. Keeping in view the current trends in dual malignancies and to further emphasize the importance of screening and follow-up diagnosis, we reviewed the records of patients who were diagnosed with dual malignancies.
Material And Methods: This is a retrospective observational study.
Rom J Morphol Embryol
July 2024
Department of Otorhinolaryngology, Dr. Vlăescu Central Polyclinic, Craiova, Romania;
Multiple primary cancers are usually defined as primary malignant tumors of different histological origins in one person. Synchronous cancers are defined as two or more primary cancers diagnosed in the same patient at the same time or within six months after identifying the first tumor, and those cancers that develop at more than a six-month interval are termed as metachronous multiple primary cancers. Our study comprised of a patient with synchronous laryngeal cancer with double localizations.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!